FENC:NASDAQ, Fennec Pharmaceuticals Inc.

FENC stock overview

Fennec Pharmaceuticals Inc. (FENC:NASDAQ) closed at $13.58 on November 17, 2026, up 6.43% on the day. The stock trades 0.4% below its 52-week high of $13.64 and 140.4% above its 52-week low of $5.65. Over the past year, it gained 55.2%. Fennec Pharmaceuticals Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).

Key figures

Price
$13.58
Day change
+6.43%
Volume
907,854
Average volume
195,762
Market cap
479M+
52-week range
$5.65 – $13.64
50-day average
$10.65
200-day average
$9.38

Price action over the past year

In 252 trading sessions since November 17, 2025, FENC closed higher on 133 days (53%). Its best day was May 14, 2026 (+36.48%) and its worst was March 24, 2026 (-19.19%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

FENC news

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.

Similar stocks

Find more stocks like FENC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.